Ultragenyx Pharmaceutical Inc. buy Barclays PLC
Start price
06.08.24
/
50%
€45.20
Target price
06.08.25
€74.24
Performance (%)
13.94%
Price
27.09.24
€48.40
Summary
This prediction is currently active. The prediction currently has a performance of 13.94%. This prediction currently runs until 06.08.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ultragenyx Pharmaceutical Inc. | -7.810% | -7.810% |
iShares Core DAX® | 3.523% | 3.763% |
iShares Nasdaq 100 | 1.026% | 2.380% |
iShares Nikkei 225® | -0.063% | 0.000% |
iShares S&P 500 | 0.557% | 2.222% |
Comments by Barclays_PLC for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target lowered by analysts at Barclays PLC from $83.00 to $81.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat